On Friday, Shares of QIAGEN N.V. (NYSE: QGEN) showed the bullish trend with a higher momentum of 0.44% to $38.85. The company traded total volume of 631,208 shares as contrast to its average volume of 1.29M shares. The company has a market value of $9.02B and about 232.22M shares outstanding.
Qiagen NV (QGEN) stated fourth-quarter net income of $61.0M, after reporting a loss in the same period a year earlier. The Venlo, Netherlands-based Company said it had profit of 26 cents per share. Earnings, adjusted for amortization costs and non-recurring costs, came to 40 cents per share. The results met Wall Street expectations. The average estimate of six analysts surveyed by Zacks Investment Research was also for earnings of 40 cents per share.
The diagnostic products maker posted revenue of $403.20M in the period, falling short of Street forecasts. Three analysts surveyed by Zacks expected $409.0M.
For the year, the company stated profit of $190.40M, or 82 cents per share. Revenue was stated as $1.50B. For the current quarter ending in April, Qiagen anticipates its per-share earnings to range from 26 cents to 27 cents. The company anticipates full-year earnings in the range of $1.45 to $1.47 per share.
The Company offered net profit margin of 12.70% while its gross profit margin was 66.80%. ROE was recorded as 7.40% while beta factor was 0.91. The stock, as of recent close, has shown the weekly upbeat performance of 1.44% which was maintained at 12.77% in this year.